Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

UNC2881

UNC2881 is a potent Mer kinase inhibitor. UNC2281 inhibits steady-state Mer kinase phosphorylation with an IC50 value of 22 nM. Treatment with UNC2281 is also sufficient to block EGF-mediated stimulation of a chimeric receptor containing the intracellular domain of Mer fused to the extracellular domain of EGFR. In addition, UNC2881 potently inhibits collagen-induced platelet aggregation, suggesting that this class of inhibitors may have utility for prevention and/or treatment of pathologic thrombosis.

Product Specifications

CAS Number

1493764-08-1

Product Name Alternative

UNC2881, UNC-2881, UNC 2881

Purity

>98% (HPLC)

Solubility

DMSO : ≥ 44 mg/mL; 94.91 mM

Smiles

CCCCNc1ncc (c (N[C@@H]2CC[C@H] (CC2) O) n1) C (=O) NCc1ccc (n2ccnc2) cc1

Molecular Formula

C25H33N7O2

Molecular Weight

463.58

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Other Product Names

N- (4- (1H-imidazol-1-yl) benzyl) -2- (butylamino) -4- (((1r,4r) -4-hydroxycyclohexyl) amino) pyrimidine-5-carboxamide

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

VNN1 antibody
OAGA01071-100UL 100 µL

VNN1 antibody

Sign In for Pricing
View Details
Nonanal
GK7344-100ml 100 mL

Nonanal

Sign In for Pricing
View Details
Monoisodecyl Phthalate-d4
456555-01 2.5 mg

Monoisodecyl Phthalate-d4

Sign In for Pricing
View Details
Monoisodecyl Phthalate-d4
456555-02 5 mg

Monoisodecyl Phthalate-d4

Sign In for Pricing
View Details
TID 1 (Tumerous Imaginal Discs 1) (BSA & Azide Free) (MaxLight750)
MBS6268177-01 0.1 mL

TID 1 (Tumerous Imaginal Discs 1) (BSA & Azide Free) (MaxLight750)

Sign In for Pricing
View Details
TID 1 (Tumerous Imaginal Discs 1) (BSA & Azide Free) (MaxLight750)
MBS6268177-02 5x 0.1 mL

TID 1 (Tumerous Imaginal Discs 1) (BSA & Azide Free) (MaxLight750)

Sign In for Pricing
View Details